NeuroEndocrine Cancer Australia (NECA) was pleased to attend the 2025 ACNNP Governance Group Day, held on 11 November at the Adelaide Convention Centre. The event provided a valuable opportunity to connect with key stakeholders, share program updates, and contribute to discussions shaping the future direction of the Australian Cancer Nurse Navigation Program (ACNNP).
Throughout the day, sessions explored navigation service progress and collaboration opportunities, updates on the McGrath Nursing model of care and the Find a Nurse tool, as well as evaluation insights from the Nous Group and discussions on embedding Optimal Care Pathways across cancer streams.
During the Collaborative Learning Session, NECA presented on Increasing Specialist Support Services, highlighting outcomes from the past 12 months and our ongoing work to expand access to expert nurse-led care. The presentation outlined:
- Pros and cons of our current specialist support model
- Updated incidence and prevalence data on neuroendocrine cancer, reinforcing its position as the seventh most common cancer in Australia
- Outcomes from our increased services, including stronger patient navigation, earlier referrals, and enhanced multidisciplinary collaboration
To conclude the day, NECA CEO Meredith Cummins met with Jamie Snashall (Senior Advisor to Health Minister Butler) to further discuss outcomes from NECA’s recent Parliamentary Event at Parliament House, Canberra, following the Senate Inquiry into equitable access to diagnosis and treatment for rare and less common cancers including neuroendocrine cancer. The conversation centred on next steps to advance implementation of the Inquiry recommendations and ensure that neuroendocrine cancer care continues to be prioritised within national cancer policy frameworks.
